UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Androgen suppresses proliferation of castration‐resistant LNCaP 104‐R2 prostate cancer cells through androgen receptor, Skp2, and c‐Myc

Cancer science, 2011-11, Vol.102 (11), p.2022-2028

2011

Volltextzugriff (PDF)

Androgen suppresses the proliferation of androgen receptor-positive castration-resistant prostate cancer cells via inhibition of Cdk2, CyclinA, and Skp2

PloS one, 2014-10, Vol.9 (10), p.e109170

2014

Volltextzugriff (PDF)

Cholestane-3β, 5α, 6β-triol suppresses proliferation, migration, and invasion of human prostate cancer cells

PloS one, 2013-06, Vol.8 (6), p.e65734-e65734

2013

Volltextzugriff (PDF)

Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer

Journal of biomedical science, 2011-08, Vol.18 (1), p.63-63

2011

Volltextzugriff (PDF)

Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells

Cancer research (Chicago, Ill.), 2004-11, Vol.64 (21), p.7686-7689

2004

Volltextzugriff (PDF)

Up-regulation of Bcl-2 is required for the progression of prostate cancer cells from an androgen-dependent to an androgen-independent growth stage

Cell research, 2007-06, Vol.17 (6), p.531-536

2007

Volltextzugriff (PDF)

Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist

Cancer research (Chicago, Ill.), 2006-07, Vol.66 (13), p.6482-6486

2006

Volltextzugriff (PDF)

Androgen causes growth suppression and reversion of androgen-independent prostate cancer xenografts to an androgen-stimulated phenotype in athymic mice

Cancer research (Chicago, Ill.), 2005-03, Vol.65 (6), p.2082-2084

2005

Volltextzugriff (PDF)

A novel potent synthetic steroidal liver X receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR–/– mice

British journal of pharmacology, 2011-04, Vol.162 (8), p.1792-1804

2011

Volltextzugriff (PDF)

Modulation of liver X receptor signaling as novel therapy for prostate cancer

Journal of biomedical science, 2007-09, Vol.14 (5), p.543-553

2007

Volltextzugriff (PDF)

Androgenic suppression of ATP-binding cassette transporter A1 expression in LNCaP human prostate cancer cells

Cancer research (Chicago, Ill.), 2004-11, Vol.64 (21), p.7682-7685

2004

Volltextzugriff (PDF)

A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function

Oncogene, 2001-02, Vol.20 (6), p.659-668

2001

Volltextzugriff (PDF)

Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks

Cancer prevention research (Philadelphia, Pa.), 2012-05, Vol.5 (5), p.788-797

2012

Volltextzugriff (PDF)

Suppression of androgen receptor signaling and prostate specific antigen expression by (−)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells

Cancer letters, 2009-03, Vol.275 (1), p.86-92

2009

Volltextzugriff (PDF)

TATA-binding Protein-associated Factor 7 Regulates Polyamine Transport Activity and Polyamine Analog-induced Apoptosis

The Journal of biological chemistry, 2004-07, Vol.279 (29), p.29921-29929

2004

Volltextzugriff (PDF)

The liver X receptor agonist T0901317 acts as androgen receptor antagonist in human prostate cancer cells

Biochemical and biophysical research communications, 2007-06, Vol.357 (2), p.341-346

2007

Volltextzugriff (PDF)

Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity

The Prostate, 2005-12, Vol.65 (4), p.287-298

2005

Volltextzugriff (PDF)

Ubiquitous Receptor: A Receptor That Modulates Gene Activation by Retinoic Acid and Thyroid Hormone Receptors

Proceedings of the National Academy of Sciences - PNAS, 1994-11, Vol.91 (23), p.10809-10813

1994

Volltextzugriff (PDF)

Human Prostate Tumor Growth in Athymic Mice: Inhibition by Androgens and Stimulation by Finasteride

Proceedings of the National Academy of Sciences - PNAS, 1996-10, Vol.93 (21), p.11802-11807

1996

Volltextzugriff (PDF)

The Effect of Diet on the Response of Low-density Lipoprotein Receptor Knockout Mice to the Liver X Receptor Agonist T1317

Journal of cardiovascular pharmacology, 2011-07, Vol.58 (1), p.102-110

2011

Volltextzugriff (PDF)

Progression of LNCaP Prostate Tumor Cells during Androgen Deprivation: Hormone-Independent Growth, Repression of Proliferation by Androgen, and Role for p27Kip1 in Androgen-Induced Cell Cycle Arrest

Molecular endocrinology (Baltimore, Md.), 1998-07, Vol.12 (7), p.941-953

1998

Volltextzugriff (PDF)

Molecular Action of Androgen in the Normal and Neoplastic Prostate

Vitamins and Hormones, 1998, Vol.55, p.219-307

1998

Volltextzugriff (PDF)

Abstract 3930: Ligand-independent activity of the mutant LNCaP androgen receptor drives cell proliferation in hormone-independent LNCaP tumor cells

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3930-3930

2012

Volltextzugriff (PDF)

Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate

Cancer letters, 1995-09, Vol.96 (2), p.239-243

1995

Volltextzugriff (PDF)

Cholestane-3[beta], 5[alpha], 6[beta]-triol Suppresses Proliferation, Migration, and Invasion of Human Prostate Cancer Cells

PloS one, 2013-06, Vol.8 (6), p.e65734

2013

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(36)
Buchkapitel
(2)

Sprache

Englisch
(38)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Androgen suppresses proliferation of castration‐resistant LNCaP 104‐R2 prostate cancer cells through androgen receptor, Skp2, and c‐Myc

Androgen suppresses the proliferation of androgen receptor-positive castration-resistant prostate cancer cells via inhibition of Cdk2, CyclinA, and Skp2

Cholestane-3β, 5α, 6β-triol suppresses proliferation, migration, and invasion of human prostate cancer cells

Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer

Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells

Up-regulation of Bcl-2 is required for the progression of prostate cancer cells from an androgen-dependent to an androgen-independent growth stage

Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist

Androgen causes growth suppression and reversion of androgen-independent prostate cancer xenografts to an androgen-stimulated phenotype in athymic mice

A novel potent synthetic steroidal liver X receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR–/– mice

Modulation of liver X receptor signaling as novel therapy for prostate cancer

Androgenic suppression of ATP-binding cassette transporter A1 expression in LNCaP human prostate cancer cells

A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function

Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks

Suppression of androgen receptor signaling and prostate specific antigen expression by (−)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells

TATA-binding Protein-associated Factor 7 Regulates Polyamine Transport Activity and Polyamine Analog-induced Apoptosis

The liver X receptor agonist T0901317 acts as androgen receptor antagonist in human prostate cancer cells

Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity

Ubiquitous Receptor: A Receptor That Modulates Gene Activation by Retinoic Acid and Thyroid Hormone Receptors

Human Prostate Tumor Growth in Athymic Mice: Inhibition by Androgens and Stimulation by Finasteride

The Effect of Diet on the Response of Low-density Lipoprotein Receptor Knockout Mice to the Liver X Receptor Agonist T1317

Progression of LNCaP Prostate Tumor Cells during Androgen Deprivation: Hormone-Independent Growth, Repression of Proliferation by Androgen, and Role for p27Kip1 in Androgen-Induced Cell Cycle Arrest

Molecular Action of Androgen in the Normal and Neoplastic Prostate

Abstract 3930: Ligand-independent activity of the mutant LNCaP androgen receptor drives cell proliferation in hormone-independent LNCaP tumor cells

Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate

Cholestane-3[beta], 5[alpha], 6[beta]-triol Suppresses Proliferation, Migration, and Invasion of Human Prostate Cancer Cells

Suchergebnisse filtern